EDIT vs HOOD · rev $32.3M vs P/E 48, rev $4.47B
Editas Medicine Inc (EDIT) versus Robinhood Markets Inc (HOOD) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vlad Tenev.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported HOOD revenue for 2025-12-31 was $4.47B. Net income was $1.88B. Revenue was up 51.6% from 2024-12-31 to 2025-12-31. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
EDIT currently screens at market cap $375.2M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Not investment advice. Open the EDIT and HOOD stock pages for the full models.
Not investment advice.